Table 2: Univariate analysis for OS in patients with classic HL.
|
Cox analysis |
B |
SE |
P value |
HR |
95.0% CI for Exp(B) |
||
|
Lower |
Upper |
||||||
|
Univariate Analysis for OS |
|||||||
|
Sex |
F vs. M |
0.296 |
0.379 |
0.435 |
1.344 |
0.640 |
2.826 |
|
Age |
< 45 vs. ≥ 45 |
1.607 |
0.438 |
0.000 |
4.985 |
2.115 |
11.753 |
|
Hemoglobin (g/L) |
≥105 ≤ 105 |
0.296 |
0.405 |
0.465 |
1.345 |
0.608 |
2.975 |
|
Elevated LDH, U/L |
No vs yes |
0.281 |
0.395 |
0.476 |
1.325 |
0.611 |
2.871 |
|
Lymphocyte count (×109/l) |
≥ 0.6 vs. < 0.6 |
-1.140 |
0.421 |
0.007 |
0.320 |
0.140 |
0.730 |
|
NLR ratio |
continuous |
0.089 |
0.032 |
0.005 |
1.093 |
1.027 |
1.163 |
|
NLR |
≤ 4.3 vs. ≥ 4.3 |
0.946 |
0.419 |
0.024 |
2.575 |
1.134 |
5.849 |
|
WBC (×109/l) |
≤ 15 vs. ≥ 15 |
0.518 |
0.461 |
0.261 |
1.679 |
0.680 |
4.148 |
|
B symptoms |
(–) vs (+) |
0.144 |
0.397 |
0.717 |
1.155 |
0.530 |
2.515 |
|
Stage |
continuous |
0.478 |
0.214 |
0.026 |
1.613 |
1.060 |
2.455 |
|
Stage |
1-3 vs. 4 |
0.620 |
0.405 |
0.126 |
1.860 |
0.841 |
4.114 |
|
GHSG |
continuous |
0.890 |
0.322 |
0.006 |
2.434 |
1.295 |
4.576 |
|
EORTC |
continuous |
0.892 |
0.341 |
0.009 |
2.440 |
1.251 |
4.759 |
|
IPS |
continuous |
0.448 |
0.135 |
0.001 |
1.565 |
1.202 |
2.039 |
|
IPS |
< 4 vs. ≥ 4 |
1.346 |
0.384 |
0.000 |
3.842 |
1.811 |
8.152 |
|
Treatment outcome |
Dead/alive |
3.406 |
0.518 |
0.000 |
30.153 |
10.925 |
83.226 |